华东医药等在杭州成立股权投资合伙企业 出资额20亿

Group 1 - A new equity investment partnership named Hangzhou Fuguang Hongze Equity Investment Partnership (Limited Partnership) has been established with a capital contribution of 2 billion RMB [1] - The managing partner of the new partnership is Niu Feng, indicating a leadership role in the investment strategy [1] - The partnership's business scope includes equity investment and venture capital, suggesting a focus on growth-oriented investments [1] Group 2 - The partnership is jointly funded by Shanghai Fuguang Private Fund Management Co., Ltd., East China Pharmaceutical (000963), Hangzhou Industrial Investment Co., Ltd., and Hangzhou Gongshu Industrial Fund Co., Ltd., highlighting a collaborative investment approach [1] - The establishment of this partnership reflects ongoing investment activity in the region, particularly in sectors related to healthcare and industrial development [1]